Clinica Baviera (CBAV.MC) Osake Kurssi
Clinica Baviera Kurssi
Liikevaihto on kasvanut 8,5 % vuodessa viimeisten 19 vuoden aikana 301,78 M EUR:een. Osakekohtainen tulos on kasvanut 10,6 % vuodessa viimeisten 17 vuoden aikana. Clinica Bavieran nettomarginaali on nyt 13,9 %, laskenut 16,2 %:sta muutama vuosi sitten. Clinica Bavieran osinkotuotto on tällä hetkellä noin 2,92 %. Jakosuhde on noin 67 % tuloksesta. Osinko on kasvanut 7,4 % vuodessa viimeisten 17 vuoden aikana. Analyytikoiden mediaanitavoitehinta on 61,20 EUR, eli yli nykyhintaa 13,8 %. 7 analyytikosta 6 suosittaa ostoa — kokonaiskonsensus on Osta.
Clinica Baviera osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
Clinica Baviera liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Clinica Baviera -osakkeesta
The main competitors of Clinica Baviera SA in the market include companies such as Opticalia, EuroEyes, and Ocular Sciences. These competitors also operate in the ophthalmology sector and provide similar services and products as Clinica Baviera SA. It is important for investors and potential customers to consider the offerings and market position of these competitors when assessing Clinica Baviera SA's market share and potential growth opportunities.
Clinica Baviera SA is a renowned company operating in the healthcare sector. The business model of Clinica Baviera SA revolves around providing high-quality medical services, specializing in ophthalmology. The company offers a range of eye care treatments, including laser refractive surgery, cataract surgery, and other specialized ophthalmic procedures. Clinica Baviera SA's focus on innovation, state-of-the-art technology, and highly trained medical professionals makes them a leading player in the field. By prioritizing patients' well-being and delivering exceptional outcomes, Clinica Baviera SA has established itself as a trusted name in the eye care industry.
Clinica Baviera SA is primarily active in the healthcare industry.
Clinica Baviera SA is a renowned company in the healthcare industry. It was established in 1989 and has since become a leading provider of ophthalmology services. The company specializes in refractive surgery, especially laser-assisted techniques like LASIK. With over 85 clinics across Europe, Clinica Baviera SA has a strong presence in countries such as Spain, Germany, Italy, and Austria. The company's success can be attributed to its team of highly skilled and experienced ophthalmologists, state-of-the-art technology, and commitment to delivering exceptional patient care. Clinica Baviera SA's continuous growth and expansion reflect its dedication to offering top-quality eye care solutions to individuals seeking improved vision.
Clinica Baviera SA has achieved several significant milestones over the years. One notable achievement is its establishment as a leading provider of ophthalmological services in Spain and Italy. Additionally, the company successfully expanded its operations to other European countries, including Germany, Austria, and Portugal. Clinica Baviera SA has also gained recognition for its cutting-edge technology and innovative treatment options, ensuring high-quality care for its patients. Moreover, the company's commitment to excellence has earned it numerous industry accolades and awards. Overall, Clinica Baviera SA continues to make strides in the field of ophthalmology, solidifying its position as a trusted and reputable healthcare provider.
Clinica Baviera SA is primarily present in Spain, where its headquarters and a majority of its clinics are located. The company has a strong presence across various regions in Spain, such as Catalonia, Andalusia, Madrid, Valencia, and Galicia. With over 25 years of experience, Clinica Baviera SA is a leading ophthalmology group in Spain, providing advanced eye care services. Its expertise, state-of-the-art technology, and commitment to patient satisfaction have earned the company a reputable position in the Spanish healthcare industry.
Clinica Baviera SA represents values such as excellence, innovation, and patient-centric care. With a strong corporate philosophy, the company is committed to providing top-quality medical services and advanced eye care treatments. Clinica Baviera focuses on customer satisfaction and takes pride in offering state-of-the-art facilities and cutting-edge technology to ensure the best outcomes for their patients. As a leader in the ophthalmology field, Clinica Baviera SA continuously strives for excellence and maintains a reputation for delivering exceptional eye care services with a patient-first approach.
Analyytikot asettavat tällä hetkellä Clinica Baviera-osakkeelle keskimääräisen tavoitehinnan 61,20 EUR (mediaani: 61,20 EUR), mikä merkitsee +13,8 % viimeisimpään hintaan verrattuna. Konsensus perustuu 7 analyytikkoarvioon.
7 analyytikkoa arvioi tällä hetkellä Clinica Baviera-osaketta: 6 suosittaa ostoa, 1 pitoa ja 0 myyntiä. Vuodelle 2026 analyytikot odottavat Clinica Baviera-yhtiöltä 331,00 M EUR liikevaihtoa ja 2,54 EUR osakekohtaista tulosta.
Clinica Baviera-osake (CBAV.MC) on listattuna 7 pörssissä, muun muassa: London (0GWJ.L), SIX (Zürich) (D9Z.SW), Frankfurt (D9Z.F), München (D9Z.MU), Düsseldorf (D9Z.DU), Madrid (CBAV.MC).
Clinica Baviera SA is a European company specialized in the treatment of vision problems. It was founded in Madrid in 2004 and is now present in Spain, Germany, Austria, Portugal, and Italy. The company offers various services, such as vision tests, eye corrections, and laser treatments. The focus is on outpatient surgical procedures, using state-of-the-art technologies such as the femtosecond laser for vision correction or the SLT laser for glaucoma treatment. Another important area for the company is cataract surgery, replacing the cloudy eye lens with an artificial lens. They also provide treatment for macular degeneration. In addition to surgical procedures, Clinica Baviera also offers non-invasive treatment methods, including the use of contact lenses or glasses. The company places high importance on the quality of its services and comprehensive patient care. Individualized consultation and accurate diagnosis are crucial before each treatment. To ensure this high quality, the company relies on a close network of specialists and doctors. Collaboration with reputable eye clinics and centers allows for expert advice on challenging cases. Research and development are also a key focus of the company. New procedures and technologies in the field of ophthalmology are developed and tested. Collaborations with scientific institutions are part of Clinica Baviera's research program. To promote its services, Clinica Baviera employs a wide marketing strategy. The company is present at trade fairs and conferences and maintains a strong online presence. It particularly utilizes social networks like Facebook and Instagram to showcase its services in an engaging and informative manner. In summary, Clinica Baviera offers a wide range of services in the field of ophthalmology. The company utilizes advanced technologies and strives for high-quality services. Through comprehensive patient care and extensive research, Clinica Baviera aims to remain a leading company in ophthalmology and continue evolving.
odotettu liikevaihto Clinica Baviera on 331,00 M EUR. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Clinica Baviera on 45,67 M EUR. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Clinica Baviera:n hinta-voitto-suhde (P/E) on tällä hetkellä 21,22. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Clinica Baviera-osakkeen arvostusta.
Clinica Baviera:n hinta-myynti-suhde (P/S) on tällä hetkellä 2,93. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Clinica Baviera-osakkeen arvostuskennuslukuna.
Clinica Baviera:n Eulpool-laatuscore on 10/10.
Clinica Baviera:n ISIN on ES0119037010. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Clinica Baviera:n WKN on A0MNAP. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Clinica Baviera:n ticker on CBAV.MC. Tämä pörssinoteeraus käytetään Clinica Baviera-osakkeiden kauppaan pörssissä.
Clinica Baviera osake
Clinica Baviera vertaisryhmä
Clinica Baviera Ticker
Clinica Baviera FIGI
Kaikki tunnusluvut ja syvällinen analyysi Clinica Baviera:sta
Meidän osakeanalyysimme Clinica Baviera-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Clinica Baviera:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: